Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ldl/Apo B Ratio Predict Coronary Heart Disease in Type 2 Diabetes Independent of Ascvd Risk Score: A Case-Cohort Study Publisher Pubmed



Rabizadeh S1 ; Rajab A1 ; Mechanick JI2 ; Moosaie F1 ; Rahimi Y1 ; Nakhjavani M1 ; Esteghamati A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, United States

Source: Nutrition# Metabolism and Cardiovascular Diseases Published:2021


Abstract

Background and aims: Coronary heart disease (CHD) is a major mortality risk factor in patients with diabetes. LDL cholesterol (LDL-C) is a major risk factor for the development of atherosclerosis. There is one apolipoprotein B (ApoB) molecule in each LDL particle. We aimed to evaluate the predictive value of the LDL-C/ApoB ratio for CHD in patients with type 2 diabetes (T2D). Methods and results: In this case-cohort study (apo)lipoproteins and glycemic indices were measured in 1058 individuals with T2D from February 2002 to March 2019, with a median duration of follow up of 10 years. Of 1058 patients with T2D, coronary heart disease occurred in 242 patients. Increased waist circumference, waist-to-hip ratio, and hemoglobin A1c, low-density lipoprotein cholesterol (LDL-C)/Apolipoprotein B (ApoB) ratio, presence of hypertension and metabolic syndrome, and insulin and statin use were more prevalent among patients with CHD (P < 0.001). Logistic regression analysis showed that an LDL-C/ApoB ratio equal or lower than 1.2 could predict CHD independent of ASCVD risk score [adjusted OR:1.841, CI:1.257–2.698, P < 0.001] when adjusted for multiple confounders. The atherogenic index of plasma (AIP) did not predict CHD. Conclusion: This study showed that LDL-C/ApoB ratio, but not the atherogenic index of plasma, may be considered as an indicator of CHD independent of the ASCVD risk score in patients with T2D. This finding merits further clarification to optimize preventive strategies for CHD. © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University
Related Docs
1. Comparison of Primary Versus Secondary Prevention of Cardiovascular Disease in Patients With Type2 Diabetes: Focus on Achievement of Abc Goals, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)
2. Associations Between Empirically Derived Dietary Patterns and Cardiovascular Risk Factors Among Older Adult Men: A Cross-Sectional Study, International Journal for Vitamin and Nutrition Research (2023)
3. The Effect of Probiotic and Synbiotic Supplementation on Lipid Parameters Among Patients With Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Clinical Trials, Cardiovascular Research (2023)
4. Atherogenic Index of Plasma Is an Independent Predictor of Metabolic-Associated Fatty Liver Disease in Patients With Type 2 Diabetes, European Journal of Medical Research (2022)
5. The Associations Between Dietary Patterns and Cardiovascular Risk Factors Among Adults: A Cross-Sectional Study, Clinical Nutrition ESPEN (2020)
6. Atherogenic Index of Plasma and Coronary Artery Disease: A Systematic Review and Meta-Analysis of Observational Studies, Cardiovascular Diabetology (2025)
7. Decreasing Trend of Blood Lipid Profile in Type 2 Diabetes: Not a Promising Change in Hdl-C, a Serial Cross-Sectional Study, PLoS ONE (2023)
Experts (# of related papers)
View all Related Experts
Soghra Rabizadeh (3)
Alireza Esteghamati (3)